This inventor holds 11 USPTO granted patents. Top assignees: Merck Frosst Canada, Inc., Merck Frosst Canada & Co., Vanderbilt University. Active years: 1996-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Quebec, CA (1998)
- Dollard des Ormeaux, CA (1996 - 2002)
- Dollar des Ormeaux, CA (1999 - 2002)
Company Filing History:
8 out of 212 
2 out of 80 
2 out of 1,220 
Years Active: 1996-2002
Title: The Innovative Mind of Richard Grygorczyk
Introduction
Richard Grygorczyk, an accomplished inventor based in Dollard des Ormeaux, Canada, has made significant contributions to the field of biomedical research with his 11 patents. His innovative work primarily focuses on prostaglandin receptors, which play a critical role in pain and inflammatory responses in the human body.
Latest Patents
Among his latest inventions, Grygorczyk has developed methods for identifying modulators of the prostaglandin receptor EP1. This advancement includes the identification and isolation of DNA encoding a novel prostaglandin receptor, which has been sequenced and expressed in host cells. The applications of this DNA and host cells are vital for discovering modulators that can influence the prostaglandin receptor's activities. Similarly, he has patented methods that identify modulators of the human IP prostaglandin receptor, showcasing his continued commitment to advancing therapeutic strategies for various health conditions.
Career Highlights
Richard has had a notable career, contributing to his expertise in the field. He has worked with renowned organizations such as Merck Frosst Canada, Inc. and Vanderbilt University. His experience in these esteemed institutions has undoubtedly enriched his understanding of pharmaceuticals and receptor biology, fuelling his innovative endeavors.
Collaborations
Throughout his career, Grygorczyk collaborated with prominent figures in the industry, including Kathleen M. Metters and Mark Abramovitz. These collaborations have allowed him to share knowledge, exchange ideas, and further enhance his innovative capabilities.
Conclusion
Richard Grygorczyk stands out as a dedicated inventor making remarkable strides in the biomedical field. With 11 patents to his name and a focus on prostaglandin receptors, his work has the potential to influence future research and medical treatments significantly. His contributions reflect the spirit of innovation and the drive to address complex health challenges through scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile